2027 MIPS Changes for Gastroenterology: Colonoscopy Measure 320 Is Gone, Now What?

Last Updated: November 13, 2026
Table of Contents
2027 MIPS Changes for GI: Colonoscopy Measure 320 Cut

What are the 2027 MIPS changes for gastroenterology?

As of November 2026, the 2027 MIPS changes for gastroenterology refer to CMS final rule policies that remove colonoscopy quality measure 320 and QCDR measure NHCR4, replace the outcome measure requirement with a new MIPS core measure requirement, and keep the 75-point performance threshold. They apply to the 2027 performance year, which sets Medicare payment adjustments in 2029.

  • Measure 320 is removed: The only colonoscopy measure GI clinicians could report through Medicare claims leaves MIPS in 2027 because CMS considers it topped out.
  • A core measure is now required: Clinicians reporting traditional MIPS or an MVP must report at least one MIPS core measure, unless none applies or the practice qualifies as small.
  • The penalty risk is unchanged: Scores below 75 points still trigger negative adjustments of up to 9% on Medicare Part B payments in 2029.

What CMS Finalized on November 4, 2026

The Centers for Medicare and Medicaid Services released the CY 2027 Physician Fee Schedule final rule on November 4, 2026, published as Federal Register document 2026-22743 (final rule text). The rule includes the Quality Payment Program updates for the 2027 performance period, and several of them land directly on gastroenterology.

First, CMS removed Quality measure 320, Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients, from MIPS and from the Gastroenterology specialty set. The measure tracked whether patients aged 45 to 75 who had a screening colonoscopy without biopsy or polypectomy received a documented 10-year follow-up recommendation. CMS removed it as topped out, meaning median performance has stayed at or above 95 percent.

Second, CMS removed QCDR measure NHCR4, which tracks whether a repeat colonoscopy is recommended within one year after inadequate bowel preparation, from the Gastroenterology Care MVP, stating that the measure no longer meets MVP inclusion criteria. CMS kept GIQIC23, Appropriate Follow-Up Interval Based on Pathology Findings in Screening Colonoscopy, unchanged after the measure steward said no updates were needed for 2027.

Third, CMS replaced the long-standing requirement to report one outcome or high priority measure with a requirement to report at least one MIPS core measure, and it eliminated the high priority designation entirely. CMS also confirmed that the 75-point performance threshold will not increase before the 2028 performance period, and it delayed the end of traditional MIPS by two years, so mandatory MVP reporting now begins with the 2031 performance period. In the companion OPPS and ASC final rule, CMS removed the same normal-colonoscopy follow-up measure from the hospital outpatient and ASC quality reporting programs, as the CMS fact sheet on the OPPS and ASC final rule notes.

Who do the 2027 MIPS changes affect?

The changes affect every MIPS eligible gastroenterologist, nurse practitioner, and physician assistant who does not report through a MIPS APM. Clinicians who relied on measure 320 through claims or MIPS CQM reporting are hit hardest, because they lose their only claims-reportable colonoscopy measure and must replace it for 2027.

CMS’s own discussion in the final rule shows how concentrated that exposure is. One commenter, citing the 2024 Quality Payment Program Experience data, noted that just over 800 individuals and groups among more than 7,000 gastroenterologists reported measure 320, and that 33 percent of them were small practices. Another commenter warned that without measure 320, gastroenterologists who do not use a qualified clinical data registry lose the only colonoscopy-specific measure available through claims and MIPS CQM collection.

Practices that report through a registry such as GIQuIC have more room, because GIQIC23 and other QCDR measures remain available. But commenters pointed out that the Gastroenterology Care MVP will be left with two colonoscopy-specific QCDR measures, GIQIC23 and GIQIC26, neither of which is eligible to be a MIPS core measure.

Small practices, defined as a tax ID with 15 or fewer clinicians, are exempt from the core measure requirement and do not need to attest when no core measure applies. Endoscopy centers are affected separately: the normal-colonoscopy follow-up measure leaves the ASC and hospital outpatient quality reporting programs starting with the 2027 reporting period, which ties to 2029 facility payment determinations.

One question we hear constantly from GI practice managers is whether quality reporting belongs with the billing team at all. In practice, measure 320 was a claims measure, so the billing team was often the one attaching the quality data codes. When that measure disappears, someone has to own the replacement.

What does losing measure 320 cost a GI practice?

Losing measure 320 costs nothing directly, but it can cost up to 9% of Medicare Part B payments in 2029 if a practice fails to replace it and falls below the 75-point MIPS threshold. A gastroenterologist with $400,000 in Medicare allowed charges could lose up to $36,000 that year.

Requirement2026 performance year2027 performance year
Colonoscopy measure 320Available by claims and MIPS CQMRemoved from MIPS
NHCR4 bowel prep measureIn the Gastroenterology Care MVPRemoved from the MVP
GIQIC23 pathology follow-upAvailable through QCDRAvailable, unchanged
Required measure typeOne outcome or high priority measureAt least one MIPS core measure
Small practices (15 or fewer)Standard requirementsExempt from core measure rule
Performance threshold75 points75 points
Maximum negative adjustment9% in 20289% in 2029

The 9% figure is the statutory maximum negative MIPS payment adjustment. Actual adjustments depend on the final score, and scores near the threshold produce smaller adjustments. The $400,000 example is illustrative, not a benchmark.

The more realistic risk is a smaller score drop. A practice that reported measure 320 at near-perfect performance earned reliable quality points from it. Its replacement may be a measure with less favorable benchmarks or one the practice has never tracked, which can pull the quality score down even if the work itself is unchanged. Quality is weighted at 30 percent of the final MIPS score for most clinicians, so a weaker quality category can be enough to move a borderline practice under 75.

These quality changes arrive on top of the payment cuts in the same rule. The non-APM conversion factor falls 2.31% to $32.63, and our coverage of 2027 Medicare GI payment changes explains how the same-day visit and practice expense policies affect endoscopy revenue. A MIPS penalty would stack on top of those reductions.

How should GI practices prepare for 2027 MIPS reporting?

GI practices should confirm their 2026 reporting path, identify a replacement for measure 320, choose at least one MIPS core measure or document that none applies, decide whether to report through a registry or the Gastroenterology Care MVP, and assign clear ownership of quality data before January 1, 2027.

  • Pull your 2026 MIPS submission and list every quality measure you reported, including measure 320.
  • Identify replacement measures with achievable benchmarks for the 2027 performance year.
  • Confirm which MIPS core measure you will report, or document why none applies to your clinicians.
  • Check whether your tax ID has 15 or fewer clinicians and qualifies for the small practice exemption.
  • Compare traditional MIPS, the Gastroenterology Care MVP, and QCDR reporting through GIQuIC for your group.
  • Update colonoscopy report templates so follow-up recommendations and bowel prep quality stay documented.
  • Assign one owner for quality data capture, whether that is the billing team, a registry, or a vendor.

The template step matters even though the measures are gone. CMS said in the final rule that removing a measure does not remove the quality action, and documented follow-up intervals still drive correct coding when a screening becomes diagnostic, which is where modifier 33 and preventive colonoscopy billing comes in. Inadequate prep documentation also supports modifier 53 for discontinued procedures when a colonoscopy cannot be completed.

Providers often come to us after a MIPS penalty letter, only to find that no one in the practice had owned quality reporting since a staff change. In our experience matching providers with billing partners, GI groups do best when the billing company either handles claims-based quality reporting directly or coordinates with the registry the practice already uses.

MIPS reporting gaps turn into 2029 payment cuts. Compare GI billing companies in our network that support quality reporting, with rates starting as low as 2.95%, and get connected in as little as 30 minutes.

Common Misreadings of the 2027 MIPS Changes

The first misreading is that removing measure 320 means colonoscopy quality no longer matters for MIPS. CMS kept GIQIC23 and other registry measures, and the seven-day post-colonoscopy hospital visit measure remains in the facility programs. The change narrows reporting options; it does not remove colonoscopy from quality scrutiny.

The second misreading is that traditional MIPS is ending in 2027. CMS proposed to retire it earlier but finalized a two-year delay. Traditional MIPS remains available through the 2030 performance period, and MVP reporting becomes mandatory starting with the 2031 performance period for clinicians not in a MIPS APM.

The third misreading is that every practice must report a core measure. Small practices with 15 or fewer clinicians are exempt, and any clinician without an applicable core measure can attest to that and report another measure instead. The attestation is required, though, so practices outside the small practice exemption cannot simply skip it.

The fourth misreading is that the ASC measure removal changes physician reporting. The facility-level removal applies to the ASC and hospital outpatient quality reporting programs, which affect facility payment updates. Physician MIPS reporting is a separate program with its own measure list.

Finally, some practices assume the threshold will rise in 2027. CMS confirmed it will stay at 75 points for 2027 and will not increase before the 2028 performance period, so the near-term risk comes from losing points on replacement measures, not from a higher bar.

In-House Reporting vs. a GI Billing Partner

Quality reporting sits awkwardly between clinical documentation, billing, and compliance. Claims-based measures like 320 needed quality data codes on the claim, registry measures need data exports, and MVP reporting adds improvement activities and cost measures. A small GI practice can easily end up with no single person responsible for the whole picture.

Across the billing companies in our network, a recurring pattern is that GI-focused teams already track screening-to-diagnostic conversions, modifier 33 and PT use, and endoscopy documentation, which are the same records quality reporting depends on. That overlap makes it practical for a billing partner to flag missing quality data before a claim goes out.

Gastroenterology Billing, powered by Billing Service Quotes, connects GI practices and endoscopy centers in all 50 states with billing companies that understand GI coding and compliance. The Billing Service Quotes network has matched more than 2,000 providers since 2024. Tim Daniels, Director of Strategic Accounts at Billing Service Quotes, personally reviews each request, and the service is free to providers because the platform is compensated by the billing companies in its network. Practices can note during the request that they need help with MIPS or registry coordination, so the introduction goes to a billing company that already supports GI quality reporting rather than one that only submits claims.

Frequently Asked Questions

Is MIPS measure 320 removed in 2027?

Yes. The CY 2027 Physician Fee Schedule final rule removes Quality measure 320, Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients, from MIPS starting with the 2027 performance period. CMS removed it because performance has been topped out, with a median rate of 95 percent or higher.

What is a MIPS core measure?

A MIPS core measure is a quality measure CMS designates as central to a specialty or MVP. Beginning in 2027, clinicians reporting traditional MIPS or an MVP must report at least one core measure, unless none applies and they attest to that, or they are in a small practice.

Is GIQIC23 still available for 2027?

Yes. GIQIC23, Appropriate Follow-Up Interval Based on Pathology Findings in Screening Colonoscopy, remains available through qualified clinical data registry reporting. CMS did not finalize its proposed modifications because the measure steward determined no updates were needed for 2027. It is not eligible to serve as a MIPS core measure.

What is the 2027 MIPS performance threshold?

The MIPS performance threshold remains 75 points for the 2027 performance period. CMS confirmed in the CY 2027 final rule that the threshold will not increase before the 2028 performance period. Scores below 75 points receive negative payment adjustments in 2029, up to a maximum of 9%.

Do small GI practices have to report a core measure?

No. Practices with 15 or fewer clinicians under one tax ID are exempt from the MIPS core measure requirement and do not need to attest when no core measure applies. They still must meet all other MIPS reporting requirements to avoid a negative payment adjustment in 2029.

When does traditional MIPS end?

Traditional MIPS remains available through the 2030 performance period. CMS finalized a two-year delay to its proposed sunset, so MVP reporting becomes the only MIPS option, other than MIPS APM reporting, starting with the 2031 performance period and the 2033 payment year.

Next Steps

Start with your 2026 MIPS submission. If measure 320 was part of it, choose its replacement and confirm your core measure plan before the 2027 performance period begins on January 1. Then confirm whether your group qualifies for the small practice exemption.

Review 2027 Medicare GI payment changes to see how the conversion factor cut and same-day visit policy affect the same claims, and keep colonoscopy templates aligned with modifier 33 and modifier 53 documentation rules.

If no one in your practice clearly owns quality reporting, get matched with a GI billing company that can coordinate it with your claims, flag missing quality data before submission, and keep your 2027 score on track. The match is free and takes as little as 30 minutes.

Get matched with a GI billing company that supports MIPS quality reporting and colonoscopy coding. Rates start as low as 2.95%, and the match is free.

Get Matched In 30 Minutes

Get a FREE Quote

Tell us about your practice and we'll connect you with trusted billing companies.

100% Free to providers — No hidden fees at any stage

Tim Daniels
Online now
Tim Daniels

How can I help?

Send me your number and I'll personally call you in less than 24 hours to discuss any questions you may have about our gastroenterology billing partners

Mon–Fri, 9:00am–5:30pm Or email instead →
Got it — talk soon.
I'll call you within one business hour. Check your phone for an unknown number.